U.S. Supreme Court Won’t Review 3rd Circuit’s Eyedrop Class Reversal

(May 22, 2018, 11:13 AM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on May 21 denied review of a prescription eyedrop case, sending the purported class action back to a New Jersey federal court for further proceedings (Alcon Laboratories, Inc., et al. v. Leonard Cottrell, et al., No. 17-1337, U.S. Sup.)....

Related Sections